Carl June of the Perelman School of Medicine and his research team discuss their unique genetic therapy that has “tamed terminal leukemia in seven out of the first 10 patients” and its risks.
Faculty & Staff
PHILADELPHIA — Periodontitis, a form of chronic gum disease that affects nearly half of the U.S. adult population, results when the bacterial community in the mouth becomes unbalanced, leading to inflammation and eventually bone loss. In its most severe form, which affects 8.5 percent of U.S. adults, periodontitis can impact systemic health.
Donors Can Make a Bigger Difference With Holiday-Giving Tips From Penn’s Center for High Impact Philanthropy
PHILADELPHIA — The holiday season sparks the spirit of giving and to help donors who are looking to make a difference for others through charitable contributions, the University of Pennsylvania’s Center for High Impact Philanthropy has released a free, online toolkit outlining the most effective opportunities.
Media Contact:Jonathan Gilad | email@example.com | 202-349-9367 December 4, 2012
Hirschmann is one of three new vice presidents who serve one-year terms on the association’s council. She is joined by Anne-Marie Slaughter of Princeton University and Hanes Walton Jr. of the University of Michigan, Ann Arbor, as APSA vice presidents.
Media Contact:Karen Kreeger | firstname.lastname@example.org | 215-349-5658 November 30, 2012
PHILADELPHIA – Five faculty members at the University of Pennsylvania have been named Fellows of the American Association for the Advancement of Science. Two are from Penn’s Perelman School of Medicine, two are from its School of Arts and Sciences and one has appointments in both schools.
For two decades, Scott Reikofski has influenced University of Pennsylvania fraternities and sororities, as well as Greek life nationally and internationally.
PHILADELPHIA — H. Lee Sweeney, Ph.D., the William Maul Measey Professor at the Perelman School of Medicine, University of Pennsylvania, has been named the inaugural director of Penn’s Center for Orphan Disease Research and Therapy. The primary mission of the Center is to expedite the translational science and development of novel therapies for rare and orphan diseases.